1 story in the last 7 days
The latest fluence pharma news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks fluence pharma across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Honasa Consumer acquired a 58% stake in nutraceuticals company Fluence Pharma for ₹135 Cr, marking entry into the nutrition and supplements space. The company plans to buy the remaining 42% over 5-7 years. Honasa also formed a new subsidiary, Honasa Health, to build the vertical.
Summaries by ByteBrief